These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
590 related articles for article (PubMed ID: 24909071)
1. 5HT3 receptor antagonist (ondansetron) reverses depressive behavior evoked by chronic unpredictable stress in mice: modulation of hypothalamic-pituitary-adrenocortical and brain serotonergic system. Gupta D; Radhakrishnan M; Kurhe Y Pharmacol Biochem Behav; 2014 Sep; 124():129-36. PubMed ID: 24909071 [TBL] [Abstract][Full Text] [Related]
2. Ondansetron, a 5HT3 receptor antagonist reverses depression and anxiety-like behavior in streptozotocin-induced diabetic mice: possible implication of serotonergic system. Gupta D; Radhakrishnan M; Kurhe Y Eur J Pharmacol; 2014 Dec; 744():59-66. PubMed ID: 25284215 [TBL] [Abstract][Full Text] [Related]
3. Effect of a novel 5-HT3 receptor antagonist 4i, in corticosterone-induced depression-like behavior and oxidative stress in mice. Gupta D; Radhakrishnan M; Kurhe Y Steroids; 2015 Apr; 96():95-102. PubMed ID: 25668613 [TBL] [Abstract][Full Text] [Related]
4. Antidepressant-like effects of a novel 5-HT3 receptor antagonist 6z in acute and chronic murine models of depression. Gupta D; Radhakrishnan M; Kurhe Y; Thangaraj D; Prabhakar V; Kanade P Acta Pharmacol Sin; 2014 Dec; 35(12):1493-503. PubMed ID: 25418380 [TBL] [Abstract][Full Text] [Related]
5. QCM-4, a 5-HT₃ receptor antagonist ameliorates plasma HPA axis hyperactivity, leptin resistance and brain oxidative stress in depression and anxiety-like behavior in obese mice. Kurhe Y; Mahesh R; Devadoss T Biochem Biophys Res Commun; 2015 Jan; 456(1):74-9. PubMed ID: 25446100 [TBL] [Abstract][Full Text] [Related]
6. Etazolate rescues behavioral deficits in chronic unpredictable mild stress model: modulation of hypothalamic-pituitary-adrenal axis activity and brain-derived neurotrophic factor level. Jindal A; Mahesh R; Bhatt S Neurochem Int; 2013 Nov; 63(5):465-75. PubMed ID: 23974048 [TBL] [Abstract][Full Text] [Related]
7. Ondansetron attenuates co-morbid depression and anxiety associated with obesity by inhibiting the biochemical alterations and improving serotonergic neurotransmission. Kurhe Y; Mahesh R Pharmacol Biochem Behav; 2015 Sep; 136():107-16. PubMed ID: 26188166 [TBL] [Abstract][Full Text] [Related]
8. A novel 5HT3 antagonist 4i (N-(3-chloro-2-methylphenyl)quinoxalin-2-carboxamide) prevents diabetes-induced depressive phenotypes in mice: Modulation of serotonergic system. Gupta D; Thangaraj D; Radhakrishnan M Behav Brain Res; 2016 Jan; 297():41-50. PubMed ID: 26454237 [TBL] [Abstract][Full Text] [Related]
9. Altered serotonergic neurotransmission but normal hypothalamic-pituitary-adrenocortical axis activity in mice chronically treated with the corticotropin-releasing hormone receptor type 1 antagonist NBI 30775. Oshima A; Flachskamm C; Reul JM; Holsboer F; Linthorst AC Neuropsychopharmacology; 2003 Dec; 28(12):2148-59. PubMed ID: 12915860 [TBL] [Abstract][Full Text] [Related]
10. Effect of (4a) a novel 5-HT3 receptor antagonist on chronic unpredictable mild stress induced depressive-like behavior in mice: an approach using behavioral tests battery. Kurhe Y; Mahesh R; Gupta D; Thangaraj D J Basic Clin Physiol Pharmacol; 2015 Jan; 26(1):25-33. PubMed ID: 24706431 [TBL] [Abstract][Full Text] [Related]
11. Antidepressant-like effect of geniposide on chronic unpredictable mild stress-induced depressive rats by regulating the hypothalamus-pituitary-adrenal axis. Cai L; Li R; Tang WJ; Meng G; Hu XY; Wu TN Eur Neuropsychopharmacol; 2015 Aug; 25(8):1332-41. PubMed ID: 25914157 [TBL] [Abstract][Full Text] [Related]
12. Protective effects of a novel 5-HT3 receptor antagonist, N-n-butyl-3-methoxy quinoxaline-2-carboxamide (6o) against chronic unpredictable mild stress-induced behavioral changes and biochemical alterations. Bhatt S; Mahesh R; Jindal A; Devadoss T Pharmacol Biochem Behav; 2014 Jul; 122():234-9. PubMed ID: 24769308 [TBL] [Abstract][Full Text] [Related]
13. QCM-4 a novel 5-HT3 antagonist attenuates the behavioral and biochemical alterations on chronic unpredictable mild stress model of depression in Swiss albino mice. Kurhe Y; Radhakrishnan M; Gupta D; Devadoss T J Pharm Pharmacol; 2014 Jan; 66(1):122-32. PubMed ID: 24180368 [TBL] [Abstract][Full Text] [Related]
14. [Effect of hesperidin on behavior and HPA axis of rat model of chronic stress-induced depression]. Cai L; Li R; Wu QQ; Wu TN Zhongguo Zhong Yao Za Zhi; 2013 Jan; 38(2):229-33. PubMed ID: 23672047 [TBL] [Abstract][Full Text] [Related]
15. Antidepressant and anti-anxiety like effects of 4i (N-(3-chloro-2-methylphenyl) quinoxalin-2-carboxamide), a novel 5-HT3 receptor antagonist in acute and chronic neurobehavioral rodent models. Gupta D; Radhakrishnan M; Thangaraj D; Kurhe Y Eur J Pharmacol; 2014 Jul; 735():59-67. PubMed ID: 24747753 [TBL] [Abstract][Full Text] [Related]
17. Ondansetron attenuates depression co-morbid with obesity in obese mice subjected to chronic unpredictable mild stress; an approach using behavioral battery tests. Kurhe Y; Radhakrishnan M; Gupta D Metab Brain Dis; 2014 Sep; 29(3):701-10. PubMed ID: 24964970 [TBL] [Abstract][Full Text] [Related]
18. Emodin opposes chronic unpredictable mild stress induced depressive-like behavior in mice by upregulating the levels of hippocampal glucocorticoid receptor and brain-derived neurotrophic factor. Li M; Fu Q; Li Y; Li S; Xue J; Ma S Fitoterapia; 2014 Oct; 98():1-10. PubMed ID: 24932776 [TBL] [Abstract][Full Text] [Related]
19. Neuropharmacological effect of novel 5-HT3 receptor antagonist, N-n-propyl-3-ethoxyquinoxaline-2-carboxamide (6n) on chronic unpredictable mild stress-induced molecular and cellular response: Behavioural and biochemical evidences. Bhatt S; Mahesh R; Jindal A; Devadoss T Pharmacol Rep; 2014 Oct; 66(5):804-10. PubMed ID: 25149984 [TBL] [Abstract][Full Text] [Related]
20. QCM-4, a serotonergic type 3 receptor modulator attenuates depression co-morbid with obesity in mice: an approach based on behavioral and biochemical investigations. Kurhe Y; Mahesh R; Gupta D; Devadoss T Eur J Pharmacol; 2014 Oct; 740():611-8. PubMed ID: 24973694 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]